[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-436220-105":59,"doc-detail-436220-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","winners-of-the-2022-honor-awards-for-excellence-at-the-annual-meeting-of-the-chinese-medical-association-taipei-part-ii-editorial-introduction","Winners of the 2022 honor awards for excellence at the annual meeting of the Chinese Medical Association-Taipei - Part II - Editorial introduction","","Editorial “Part II” introduces three recipients of the Journal of the Chinese Medical Association’s 2022 Excellent Research Paper Awards announced at the Chinese Medical Association-Taipei Annual Meeting on July 8–9, 2023. It summarizes winners’ work with emphasis on advances in understanding and caring for patients. The lead focus discusses liver cirrhosis pathophysiology and how lycopene may mitigate bile-duct-ligation–induced cirrhosis via effects on hyperdynamic circulation, angiogenesis, and fibrosis, while noting remaining gaps for translation to clinical practice.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/winners-of-the-2022-honor-awards-for-excellence-at-the-annual-meeting-of-the-chinese-medical-association-taipei-part-ii-editorial-introduction/436220/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/winners-of-the-2022-honor-awards-for-excellence-at-the-annual-meeting-of-the-chinese-medical-association-taipei-part-ii-editorial-introduction/436220.png","ImageObject",300,407,{"name":92,"@type":93},"Rowan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-29",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What does this editorial Part II cover?","Question",{"text":112,"@type":113},"It presents three winners of the 2022 Excellent Research Paper Awards at the Chinese Medical Association-Taipei Annual Meeting and summarizes their achievements.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which biomedical topic is highlighted in the main discussion?",{"text":117,"@type":113},"The editorial emphasizes liver cirrhosis pathophysiology, complications driven by portal hypertension and angiogenesis, and approaches to slow disease progression.",{"name":119,"@type":110,"acceptedAnswer":120},"How is lycopene described as potentially beneficial?",{"text":121,"@type":113},"It is discussed as improving bile-duct-ligation–induced cirrhosis severity by affecting hyperdynamic circulation, intrahepatic angiogenesis, fibrosis, and related molecular pathways, while antioxidant and non-oxidative effects are considered.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},436220,1791059809,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":81,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":39,"preview_page_count":4},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","J Chin MedAssoc  \nEditorial  \nWinners of the 2022 honor awards for excellence at the annual meeting of the Chinese Medical Association-Taipei: Part II  \nPeng-Hui Wanga,b,c,*, Teh-Ia Huod,e  \naDepartment of Obstetrics and Gynecology, Taipei Veterans General Hospital, Taipei, Taiwan, ROC; bInstitute of Clinical Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC; cFemale Cancer Foundation, Taipei, Taiwan, ROC; dDepartment of Medical Research, Taipei Veterans General Hospital, Taipei, ROC; eInstitute of Pharmacology, National Yang Ming Chiao Tung University, Taipei, Taiwan, ROC  \nThe present editorial is a “Part II” after “Part I” outstanding research works,1–3 which announced another three 2022 Excellent Research Paper Awards of the Journal of the Chinese Medical Association (JCMA) at the Chinese Medical Association-Taipei Annual Meeting (CMA-Taipei) on July 8 and July 9, 2023, held at Taipei, Taiwan. We are happy to introduce three winners with their great achievement on promotion of professional and scientific advances in taking care of patients and increasing better understanding in medicine.4–6  \nFirst, Dr. Huang and colleagues4 have long-term studied the pathophysiology, prevention and treatment in liver cirrhosis, which is a major cause of disability and mortality in Taiwan, resulting in a biggest health issue and heavy economic social burden.7–9 Liver cirrhosis, characterized by liver fibrosis and pathological angiogenesis, is considered end stage of liver disease, transcending various progressive stages from compensation to decompensation driven by the severity of portal hypertension and subsequent association with cardinal and hemodynamic complication, such as development of ascites, variceal hemorrhage, and hepatic encephalopathy, hepatorenal syndrome and cirrhotic cardiomyopathy and finally resulting in death.10 Slowing down the progression of severity of portal hypertension may be one of the most critical steps to delay or reverse the cirrhosis-related complications, which can be mediated by blocking an abnormal and hyperdynamic circulation of liver cirrhosis. Dr. Huang et al4 used the bile duct ligation (BDL) -induced biliary cirrhotic rat model to investigate the effect of lycopene on ameliorating the severity of BDL-induced cirrhosis and pathological angiogenesis. The results were impressive and exciting, including alleviating hyperdynamic circulation such  \n* Address correspondence. Dr. Peng-Hui Wang, Department of Obstetricsand Gynecology, Taipei Veterans General Hospital, 201, Section 2, Shi-Pai Road, Taipei 112, Taiwan, [ROC. E-mail addresses: phwang@vghtpe.gov.tw](ROC. E-mail addresses: phwang@vghtpe.gov.tw); [pongpongwang@gmail.com](pongpongwang@gmail.com) (P.-H. Wang).  \nConflicts of interest: Dr. Peng-Hui Wang and Dr. Teh-Ia Huo, editorial board members at the Journal of the Chinese Medical Association, had no roles in the peer review process of or decision to publish this article. Both the authors declare no conflicts of interest related to the subject matter or materials discussed in this article.  \nJournal of Chinese Medical Association. (2023) 86: 947-949.  \nReceived July 15, 2023; accepted July 18, 2023.  \ndoi: 10. 1097/JCMA.0000000000000971.  \nCopyright © 2023, the Chinese Medical Association. This is an open access article under the CC BY-NC-ND license ([http://creativecommons.org/licenses/](http://creativecommons.org/licenses/)[ ](http://creativecommons.org/licenses/)[by-nc-nd/4.0/](by-nc-nd/4.0/))  \nas decreased cardiac index and increased peripheral vascular resistance, as well as diminishing the shunting degree of portalsystem collaterals and mesenteric vascular density, and of most importance, ameliorating intrahepatic angiogenesis and severity of liver fibrosis.4 The authors further investigated the associated underlying mechanisms of lycopene on the positive impact on protecting disease progression of liver cirrhosis, and found that lycopene can upregulated endothelial nit","cbCaijtmOnfahN1m","https://ap.wps.com/l/cbCaijtmOnfahN1m","pdf",295166,"English","# Editorial\n## Part II award introduction\n## Study focus: liver cirrhosis and lycopene mechanisms\n## Translational challenges and limitations","[{\"question\":\"What does this editorial Part II cover?\",\"answer\":\"It presents three winners of the 2022 Excellent Research Paper Awards at the Chinese Medical Association-Taipei Annual Meeting and summarizes their achievements.\"},{\"question\":\"Which biomedical topic is highlighted in the main discussion?\",\"answer\":\"The editorial emphasizes liver cirrhosis pathophysiology, complications driven by portal hypertension and angiogenesis, and approaches to slow disease progression.\"},{\"question\":\"How is lycopene described as potentially beneficial?\",\"answer\":\"It is discussed as improving bile-duct-ligation–induced cirrhosis severity by affecting hyperdynamic circulation, intrahepatic angiogenesis, fibrosis, and related molecular pathways, while antioxidant and non-oxidative effects are considered.\"}]","Winners of the 2022 honor awards for excellence at the annual meeting of the Chinese Medical Association-Taipei - Part II - Editorial introduction | PDF",1790677191]